Zentrum

Zentrum Biotecnologia is a pioneering Brazilian biotechnology company specializing in the development and manufacturing of advanced therapies, particularly CAR-T cell treatments for hematological malignancies. Based in Ribeirão Preto, the company operates a state-of-the-art GMP facility that is among the first in Latin America dedicated to the production of cell and gene therapy products, including viral vectors. Zentrum works in close collaboration with the Hemocentro de Ribeirão Preto and the University of São Paulo to translate cutting-edge academic research into accessible clinical applications. Their lead clinical programs focus on CD19-targeted CAR-T cells, which are currently being evaluated in trials for patients with leukemia and lymphoma within the Brazilian healthcare system.